Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
Intravitreal injections of aflibercept biosimilar can significantly reduce DME, improve BCVA, enhance macular perfusion, and restore macular function.
Authors
- Gaixia Zhai (ORCID: https://orcid.org/0000-0002-9882-7780)
- Yuanzhen Su (ORCID: https://orcid.org/0009-0000-2081-8254)
- Xia Zhang (ORCID: https://orcid.org/0009-0001-5748-4371)
- Chao Sun (ORCID: https://orcid.org/0000-0002-5969-0179)
Institutions
- Central Hospital of Zibo (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-03-24
- DOI
- https://doi.org/10.3389/fmed.2025.1528104
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00